Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
UPD | Revenue guidance | 16/01/24 | 239 | 191K | |||
|
|||||||
UPD | Ann: Removal from the Official List | 21/02/22 | 1 | 2.0K | |||
|
|||||||
UPD | GMV Delisting | 14/08/20 | 0 | 972 | |||
|
|||||||
UPD | Payment for securities bought back | 29/12/18 | 13 | 7.1K | |||
|
|||||||
UPD | CDI conversion | 12:56 | 3 | 3.3K | |||
|
|||||||
UPD | Ann: Letter from the CEO | 17/10/18 | 3 | 5.2K | |||
|
|||||||
UPD | Ann: Suspension from Official Quotation | 09/10/18 | 2 | 4.7K | |||
|
|||||||
UPD | Ann: Notice of Initial Substantial Shareholder | 02/10/18 | 12 | 8.3K | |||
|
See All Discussions